PeopleofSuperintelligence

Researcher

Andrew H. Beck

Also known as Andrew Beck, Andy Beck, A H Beck, A. Beck, A. H. Beck, A.H. BECK, A.H. Beck

Andrew Beck is a biomedical-informatics researcher whose work applies machine learning to cancer pathology. He earned an MD from Brown, completed anatomic pathology residency and molecular genetic pathology fellowship at Stanford, and earned a Stanford PhD in biomedical informatics. At Stanford, he first-authored C-Path research that used tissue images to predict breast-cancer survival; in 2016, his deep-learning team won both tasks in an ISBI challenge and reduced human error when pathologists used its predictions. He co-founded PathAI in 2016, and the company later partnered with GSK, launched AISight, and received FDA clearance for AISight Dx primary diagnosis. As of October 2026, he is PathAI’s CEO and co-founder and Global Head of Digital Pathology at Roche.

Now at
PathAI and Roche
Works
477
Badges
Links
X and LinkedIn

Publication numbers from OpenAlex, as of 22 October 2026. Citations and h-index are hidden because this OpenAlex record may be incomplete or mix in other authors.

Timeline

  1. 2006–2013

    Brown and Stanford training

    In 2006, he earns an MD from Brown’s Warren Alpert Medical School. He completes residency and fellowship training in anatomic pathology and molecular genetic pathology at Stanford, and earns a PhD in biomedical informatics there in 2013.

  2. 2011

    C-Path and cancer survival

    In November 2011, he is a doctoral candidate in biomedical informatics at Stanford and first author of a study introducing C-Path, a machine-learning method that analyzes breast-cancer images to predict survival. C-Path measures 6,642 cellular factors and outperforms human-based evaluation.

  3. 2016

    A deep-learning challenge win

    In 2016, he coauthors a deep-learning system for detecting metastatic breast cancer in whole-slide images of sentinel lymph-node biopsies. The team wins both tasks in an ISBI grand challenge, with a whole-slide classification AUC of 0.925. Combining its predictions with a pathologist’s diagnosis raises AUC to 0.995 and reduces human error by about 85 percent.

  4. 2016

    Co-founding PathAI

    PathAI is founded in 2016 with Beck as a co-founder. The company applies technology to pathology to reduce diagnostic error and improve accuracy and reproducibility.

  5. April 2022

    A GSK research partnership

    In April 2022, he describes a multi-year PathAI–GSK partnership that combines the companies’ AI and platform engineering teams to scale algorithm development and integrate new insights into clinical trials. The partners aim to use machine learning to predict which patients may benefit from therapies.

  6. August 2023

    AISight image management

    In August 2023, he introduces AISight, a digital pathology image-management system for anatomic pathology laboratories. The platform builds on PathAI’s algorithm-development and machine-learning work.

  7. July 2025

    FDA clearance for AISight Dx

    In July 2025, he speaks as PathAI’s co-founder and CEO after AISight Dx receives FDA clearance for primary diagnosis in clinical settings. The clearance supports use with the Hamamatsu NanoZoomer S360MD and Leica Aperio GT 450 Dx scanners.

  8. As of October 2026

    Digital pathology at Roche

    He serves as Global Head of Digital Pathology at Roche and CEO and co-founder at PathAI.

Career

  1. Since 2016PathAICo-founder, CEO
  2. NowRocheGlobal Head of Digital Pathology

Education

  1. 2013Stanford UniversityAnatomic pathology residency
  2. 2006Brown UniversityMD

From the biography.

  1. The company share of AI researchers’ top papers was 31% in 2020–2024 and 8% in 1970–1974Includes Roche. We estimate where the people shaping AI worked when their most-cited papers appeared: the company share was 31% in 2020–2024 and 8% in 1970–1974, and Google led all organizations in 2020–2024.
  2. 20% of people at companies who shape AI also hold a university role, led by Google and Stanford UniversityIncludes Stanford University. We estimate that 539 of the 6,766 people with a known current organization (8%) hold both a university role and a company role, including 20% of people at companies and 13% of people at universities.
  3. Google had the most people shaping AI every year from 2014 to 2025Includes Stanford University. Our estimates of which organizations employed the most people shaping AI each year from 1955 to 2025, tracing the shift from university labs to companies.
  4. More people shaping AI studied at Massachusetts Institute of Technology than at any other institutionIncludes Stanford University. We estimate where the people shaping AI studied and where their careers led. Massachusetts Institute of Technology leads with 467 former students, including 291 recorded doctorates.

Colleagues

People with dated positions at the same organization in the same years.

Sources and credits

Photo: We have no published photo of Andrew H. Beck yet. Send us a free-licensed photo.

  1. Andrew Beck, PathAI | Boston Tech Leaders - The Boston Globe bostonglobe.com. Checked 20 October 2026.
  2. Andy Beck, MD, PhD pathai.com. Checked 20 October 2026.
  3. Stanford team trains computers to evaluate breast cancers engineering.stanford.edu. Checked 20 October 2026.
  4. Deep Learning for Identifying Metastatic Breast Cancer arxiv.org. Checked 20 October 2026.
  5. About PathAI pathai.com. Checked 20 October 2026.
  6. PathAI and GlaxoSmithKline Sign Multi-Year Agreement to Accelerate Research and Drug Development pathai.com. Checked 20 October 2026.
  7. Expanding into Digital Diagnostics: Letter from Andy Beck, MD, PhD - Co-Founder and CEO of PathAI pathai.com. Checked 20 October 2026.
  8. Discussion with the Expert: Q&A with Founder/CEO Andrew Beck, M.D., Ph.D., on AISight® Dx FDA Clearance and the Future of Digital Pathology pathai.com. Checked 20 October 2026.
  9. 2026 PQG Conference Speakers hsph.harvard.edu. Checked 20 October 2026.